Saturday 17 October 2026
Export TPB’s income statement to Excel — free account
Turning Point Brands, Inc.
TPB Consumer Defensive Tobacco
Turning Point Brands, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $463.1 million, up 28.4% from fiscal 2024. In the quarter to June 2026, revenue grew 22.6%, EPS fell 77.8%, free cash flow grew 235.1% and total debt was flat, each against the same quarter a year earlier. Dividend growth for five consecutive years, revenue growth for three.
62.69
2.38
+3.95%
Follow TPB
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
35.63 | 28.83 | 33.77 | 33.86 |
+8 more quarters Free account |
P/S ratio |
3.33 | 3.47 | 4.29 | 4.14 | |
P/FCF ratio |
85.93 | 1,363.52 | 45.28 | 46.29 | |
P/Operating CF |
64.08 | (74.92) | 79.86 | 549.13 | |
P/B ratio |
3.72 | 4.33 | 5.34 | 5.04 | |
Price to Tangible BV |
6.62 | 8.98 | 11.55 | 11.44 | |
EV/Sales |
3.61 | 3.92 | 4.70 | 4.62 | |
EV/EBITDA |
21.53 | 20.04 | 20.82 | 19.74 | |
EV/Operating CF |
56.85 | 106.60 | 37.90 | 40.09 | |
EV/FCF |
93.28 | 1,543.34 | 49.60 | 51.70 | |
Quick Ratio |
3.30 | 3.09 | 3.31 | 3.21 | |
Current Ratio |
5.67 | 5.87 | 5.56 | 5.56 | |
Net Debt/EBITDA |
1.32 | 6.78 | 3.17 | 3.27 | |
Debt/Assets |
34.40% | 38.06% | 38.45% | 39.49% | |
Debt/Equity |
0.65 | 0.76 | 0.79 | 0.82 | |
Asset Turnover |
0.70 | 0.72 | 0.74 | 0.71 | |
Operating CF/Net income |
7.32 | (1.91) | 3.03 | 0.16 | |
Capex/Depreciation |
(0.03) | (2.07) | (1.38) | (1.72) | |
Interest Coverage |
3.93 | 2.82 | 4.55 | 7.33 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
53.85% | 44.91% | 39.44% | 37.44% | |
Intangible Assets out of Total Assets |
0.23 | 0.26 | 0.26 | 0.27 | |
Share Based Compensation of Revenue |
1.89% | 2.36% | 1.49% | 1.58% | |
Graham Net Nets |
0.06 | 0.02 | 0.01 | 0.01 | |
Graham Number |
34.96 | 36.86 | 38.30 | 35.91 | |
Earnings Yield |
2.81% | 3.47% | 2.96% | 2.95% | |
Free Cash Flow Yield |
1.16% | 0.07% | 2.21% | 2.16% | |
Revenue per Share |
7.19 | 6.47 | 6.61 | 6.52 | |
Operating CF per Share |
1.32 | (1.16) | 1.36 | 0.18 | |
Capex per Share |
0.00 | (0.27) | (0.18) | (0.22) | |
Free Cash Flow per Share |
1.32 | (1.43) | 1.17 | (0.04) | |
Cash per Share |
13.49 | 10.02 | 12.16 | 11.03 | |
Shareholders Equity per Share |
22.83 | 20.06 | 20.31 | 19.63 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
22.83 | 20.06 | 20.31 | 19.63 | |
Free Cash Flow |
26.24 | (27.40) | 21.51 | (0.72) | |
Working Capital |
411.92 | 346.92 | 342.14 | 325.10 | |
Capital Expenditures |
(0.09) | (5.14) | (3.35) | (4.01) | |
Net Current Asset Value |
98.96 | 31.60 | 25.38 | 11.74 | |
EV/EBIT |
24.41 | 22.31 | 22.81 | 21.60 | |
Capex to Sales |
0.00 | 0.04 | 0.03 | 0.03 | |
Price to Operating Income |
22.49 | 19.71 | 20.83 | 19.34 | |
| Other line items | |||||
Average Receivables |
26.38 | 21.17 | 17.68 | 19.19 | |
Average Payables |
30.73 | 31.45 | 16.05 | 19.02 | |
Average Inventory |
119.22 | 117.01 | 102.12 | 109.60 | |
Average Assets |
725.49 | 668.32 | 628.55 | 615.43 | |
Average Common Equity |
339.42 | 294.46 | 281.18 | 272.46 |
Columns are period end dates